Polymorphisms in the TNF-α promoter have been described in leukemia, as the frequency of TNF-α-308 G/A polymorphism in ALL and CLL cases is associated with a higher risk of death. This evidence concerns the gene TNF and B-cell chronic lymphocytic leukemia.